ASCRS 2020: Evolution of an administration technique for DEXYCU

May 31, 2020
Alex Delaney-Gesing

Ophthalmology Times' David Hutton speaks with Michael Saidel, MD, a cornea and cataract specialist, on his presentation regarding "Evolution of an administration technique for DEXYCU (dexamethasone intraocular suspension) 9%" during the 2020 ASCRS virtual meeting.
 

See more ASCRS coverage here 

Related Content:

ASCRS | News